Pure Global
NCT05771974

The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy

A Randomized Controlled Trial Using Surgical Gloves to Prevent Chemotherapy-induced Peripheral Neuropathy by Paclitaxel in Breast Cancer Patients
Young-Joon Kang·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chemotherapy-induced Peripheral Neuropathy
Drug/Device/Intervention
Compression therapy using surgical gloves
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Young-Joon Kang
Funder
Incheon St.Mary's Hospital
Timeline & enrollment
Phase
N/A
Start date
May 01, 2023
End date
Feb 01, 2026
Enrollment
104 participants
Primary outcome

Changes in the 11 items neurotoxicity component of the Functional Assessment of Cancer Therapy-Taxane (FACT-NTX) Therapy subscale

Summary

This study aims to demonstrate the preventive effect of compression therapy using surgical
 gloves in chemotherapy-induced peripheral neuropathy. Patient-reported outcome measures
 (PROMs) are utilized for comparing the change in neuropathic pain between intervention and
 control groups. Among the PROMs, the neurotoxicity component of the functional Assessment of
 Cancer Therapy-taxane (FACT-Tax) is used for good and poor outcomes between baseline and
 post-chemotherapy in paclitaxel-treated breast cancer patients.

ICD-10 classifications
Drug-induced polyneuropathyParaneoplastic neuromyopathy and neuropathyPolyneuropathy due to other toxic agentsIdiopathic peripheral autonomic neuropathyIdiopathic progressive neuropathy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05771974
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05771974 through Pure Global AI's free database. This phase not specified trial is sponsored by Young-Joon Kang and is currently Not yet recruiting. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 104 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.